Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial

• Hlavní autoři: Ala Ghobadian (Autor), Saba Mokhtari (Autor), Behnam Shariati (Autor), Leila Kamalzadeh (Autor), Mohsen Shati (Autor), Mehrdad Eftekhar Ardebili (Autor), Masoomeh Yarahmadi (Autor), Mohammadreza Shalbafan (Autor)
• Médium: Kniha
• Vydáno: BMC, 2022-09-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Background Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20-30%, and satisfactory treatment is obtained in 40-60% of patients with OCD. Nevertheless, the remaining symptoms continue to impair...